Crossmark

Erratum to: Efficacy of sacubitril–valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00059-024-05283-w

Published Online: 2024-10-29

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baía Bezerra, Fernando https://orcid.org/0009-0007-2587-4176
Rodrigues Sobreira, Luis Eduardo https://orcid.org/0009-0003-3006-5489
Tsuchiya Sano, Vitor Kendi https://orcid.org/0000-0001-8317-1857
de Oliveira Macena Lôbo, Artur https://orcid.org/0009-0003-0637-0387
Cavalcanti Orestes Cardoso, Jorge Henrique https://orcid.org/0000-0003-0316-8047
Alves Kelly, Francinny https://orcid.org/0000-0003-0706-6929
Aquino de Moraes, Francisco Cezar https://orcid.org/0000-0003-0623-8135
Consolim-Colombo, Fernanda Marciano https://orcid.org/0000-0003-3220-019X
License Information

Text and Data Mining valid from 2024-10-29

Version of Record valid from 2024-10-29
More Information

Article History

First Online: 29 October 2024

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below